233 related articles for article (PubMed ID: 16690364)
1. SIRS and group-B streptococcal sepsis in newborns: pathogenesis and perspectives in adjunctive therapy.
Henneke P; Berner R
Semin Fetal Neonatal Med; 2006 Oct; 11(5):333-42. PubMed ID: 16690364
[TBL] [Abstract][Full Text] [Related]
2. The innate immune system and its relevance to neonatal sepsis.
Kenzel S; Henneke P
Curr Opin Infect Dis; 2006 Jun; 19(3):264-70. PubMed ID: 16645488
[TBL] [Abstract][Full Text] [Related]
3. [Infection with group B streptococci in newborn infants and children. An overview of clinically relevant results of the last 10 years].
Roos R; Bühler S; Kraeft H; Handrick W
Ergeb Inn Med Kinderheilkd; 1992; 60():103-49. PubMed ID: 1582402
[No Abstract] [Full Text] [Related]
4. [Successful continuous renal replacement therapy in a neonate with early-onset group B streptococcal sepsis and multi-organ dysfunction syndrome].
von Schnakenburg C; Hufnagel M; Superti-Furga A; Rieger-Fackeldey E; Berner R
Klin Padiatr; 2009; 221(4):251-3. PubMed ID: 19199225
[TBL] [Abstract][Full Text] [Related]
5. Molecular pathogenesis of neonatal group B streptococcal infection: no longer in its infancy.
Doran KS; Nizet V
Mol Microbiol; 2004 Oct; 54(1):23-31. PubMed ID: 15458402
[TBL] [Abstract][Full Text] [Related]
6. Different sequence strains of Streptococcus agalactiae elicit various levels of cytokine production.
De Francesco MA; Gargiulo F; Negrini R; Gelmi M; Manca N
Immunol Invest; 2008; 37(8):741-51. PubMed ID: 18991093
[TBL] [Abstract][Full Text] [Related]
7. Temporal alterations in concentrations of sera cytokines/chemokines in sepsis due to group B streptococcus infection in a neonate.
Okazaki K; Kondo M; Kato M; Nishida A; Takahashi H; Noda M; Kimura H
Jpn J Infect Dis; 2008 Sep; 61(5):382-5. PubMed ID: 18806347
[TBL] [Abstract][Full Text] [Related]
8. Probable early-onset group B streptococcal neonatal sepsis: a serious clinical condition related to intrauterine infection.
Carbonell-Estrany X; Figueras-Aloy J; Salcedo-Abizanda S; de la Rosa-Fraile M;
Arch Dis Child Fetal Neonatal Ed; 2008 Mar; 93(2):F85-9. PubMed ID: 17704105
[TBL] [Abstract][Full Text] [Related]
9. The effects of interferon-gamma and transforming growth factor-beta on adherence and survival of group B Streptococcus type III strains in ECV304 cells.
Santos GS; Miyazaki NH; Mattos-Guaraldi AL; Nagao PE
Int J Mol Med; 2003 Mar; 11(3):401-6. PubMed ID: 12579348
[TBL] [Abstract][Full Text] [Related]
10. Induction and termination of inflammatory signaling in group B streptococcal sepsis.
Wennekamp J; Henneke P
Immunol Rev; 2008 Oct; 225():114-27. PubMed ID: 18837779
[TBL] [Abstract][Full Text] [Related]
11. Isolation and identification of the group B streptococcal toxin CM101 from infants with sepsis.
Sundell HW; Yan H; Carter CE; Wamil BD; Wu K; Gaddipati R; Li D; Hellerqvist CG
J Pediatr; 2000 Sep; 137(3):338-44. PubMed ID: 10969257
[TBL] [Abstract][Full Text] [Related]
12. Immunological fingerprinting of group B streptococci: from circulating human antibodies to protective antigens.
Meinke AL; Senn BM; Visram Z; Henics TZ; Minh DB; Schüler W; Neubauer C; Gelbmann D; Noiges B; Sinzinger J; Hanner M; Dewasthaly S; Lundberg U; Hordnes K; Masoud H; Sevelda P; von Gabain A; Nagy E
Vaccine; 2010 Oct; 28(43):6997-7008. PubMed ID: 20732466
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor-dependent discrimination of streptococci.
Santos-Sierra S; Golenbock DT; Henneke P
J Endotoxin Res; 2006; 12(5):307-12. PubMed ID: 17059694
[TBL] [Abstract][Full Text] [Related]
14. [Neonatal Streptococcus group B sepsis: problems of early diagnosis, therapy and prevention].
Kind C; Gnehm H; Seger R; Duc G
Helv Paediatr Acta; 1984 Dec; 39(5-6):419-38. PubMed ID: 6399717
[TBL] [Abstract][Full Text] [Related]
15. Secreted group IIA phospholipase A2 protects humans against the group B streptococcus: experimental and clinical evidence.
Movert E; Wu Y; Lambeau G; Kahn F; Touqui L; Areschoug T
J Infect Dis; 2013 Dec; 208(12):2025-35. PubMed ID: 23901095
[TBL] [Abstract][Full Text] [Related]
16. Bacterial genetics and human immunity to group B streptococci.
Adderson EE; Takahashi S; Bohnsack JF
Mol Genet Metab; 2000; 71(1-2):451-4. PubMed ID: 11001839
[TBL] [Abstract][Full Text] [Related]
17. Late-onset neonatal infections caused by group B Streptococcus associated with viral infection.
Raymond J; Armengaud JB; Lambe C; Tchetchoua A; Moulin F; Lebon P; Poyart C; Gendrel D
Pediatr Infect Dis J; 2007 Oct; 26(10):963-5. PubMed ID: 17901809
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to tumor necrosis factor-alpha: use as adjunctive therapy in established group B streptococcal disease in newborn rats.
Givner LB; Gray L; O'Shea TM
Pediatr Res; 1995 Oct; 38(4):551-4. PubMed ID: 8559608
[TBL] [Abstract][Full Text] [Related]
19. Invasive group B Streptococcal disease in non-pregnant adults : a review with emphasis on skin and soft-tissue infections.
Sendi P; Johansson L; Norrby-Teglund A
Infection; 2008 Mar; 36(2):100-11. PubMed ID: 18193384
[TBL] [Abstract][Full Text] [Related]
20. Group B streptococcal and pneumococcal sepsis in newborn infants: the role of pneumococcal antibody.
Fischer GW; Bass JW; Lowell GH; Crumrine MH
Pediatrics; 1978 Oct; 62(4):620-1. PubMed ID: 30938
[No Abstract] [Full Text] [Related]
[Next] [New Search]
